Figure 1: DDRi overwhelms cellular DNA damage responses and induces cancer cell death.

Targeted DDRi agents inactivate key DNA repair pathways, causing accumulation of double-stranded DNA breaks. This double-stranded DNA break accumulation, combined with increased dependence on error-prone repair mechanisms, overwhelms cellular damage tolerance and promotes cancer cell death.